Transactions
DISCLAIMER: Transaction value is approximate and is based on information disclosed by the parties to the transaction or other public sources. In addition, in the case of transactions consummated in currencies other than U.S. dollars, Lazard has converted the value using the exchange rate published on the date of announcement. Lazard makes no representation or warranty with respect to the accuracy or completeness of the value provided
Download results
Showing 3911 to 3920 of 5360 Results
June 23, 2010
Advising company with respect to evaluation of financial and strategic alternatives.
$575 Million
June 22, 2010
Registered direct offering of common stock and warrants
$10 Million
June 21, 2010
Gala Coral Restructuring Successfully Completed
$4.5 Billion
June 17, 2010
Initial public offering
$390 Million
June 14, 2010
Thompson Street Capital Partners to sell DCL Medical Laboratories to Laboratory Corporation of America
Undisclosed
June 11, 2010
TF1 to acquire NT1 and TMC
$400 Million
June 11, 2010
Advising the company in connection with Chapter 11 bankruptcy reorganization
$1.6 Billion
June 10, 2010
GSK announces acquisition of Laboratorios Phoenix
$253 Million
June 09, 2010
Astellas Pharma to Acquire OSI Pharmaceuticals
$4 Billion
June 09, 2010